A phase II trial of Xeloda and oxaliplatin (XELOX) neo-adjuvant chemotherapy followed by surgery for advanced gastric cancer patients with para-aortic lymph node metastasis

PURPOSE: Gastric cancer with para-aortic lymph node (PAN) involvement is regarded as advanced disease, and only chemotherapy is recommended from the guidelines. In unresectable cases, neoadjuvant chemotherapy could prolong survival if conversion to resectability could be achieved. METHODS: The study...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yan, Yu, Yi-yi, Li, Wei, Feng, Yi, Hou, Jun, Ji, Yuan, Sun, Yi-hong, Shen, Kun-tang, Shen, Zhen-bin, Qin, Xin-yu, Liu, Tian-shu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4032640/
https://www.ncbi.nlm.nih.gov/pubmed/24748418
http://dx.doi.org/10.1007/s00280-014-2449-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4032640/
https://www.ncbi.nlm.nih.gov/pubmed/24748418
http://dx.doi.org/10.1007/s00280-014-2449-1

Ejemplares similares